Active HHV-6 infection in the lymph nodes of HIV-infected patients: In vitro evidence that HHV-6 can break HIV latency

被引:39
作者
Knox, KK [1 ]
Carrigan, DR [1 ]
机构
[1] MED COLL WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53226
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1996年 / 11卷 / 04期
关键词
HHV-6; lymph node; latency HIV;
D O I
10.1097/00042560-199604010-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies published previously by this laboratory have demonstrated that patients with AIDS have widely disseminated, active infections with HHV-6 at the time of their death. However, it remains unclear when in the course of the human immunodeficiency virus (HIV) infection the active HHV-6 infection first appears. To address this question, lymph node biopsies from 10 HIV-infected patients were analyzed for active human herpesvirus 6 (HHV-6) infections by immunohistochemical staining. Eight of the biopsies carried the histologic diagnosis of follicular hyperplasia; the other two were characterized as having follicular involution with histiocytosis and reactive lymphadenitis. In total, 10 of 10 (100%) of the lymph nodes studied contained cells productively infected with HHV-6; in contrast, three lymph nodes with follicular hyperplasia and four normal lymph nodes from patients not infected with HIV were negative for HHV-6 infection. Of special note, the absolute CD4(+) lymphocyte counts of 75% (6/8) of the HIV-infected individuals included in these studies were >200/mm(3) at the time of their lymph node biopsy. The A variant of HHV-6 was found to be the predominant form of the virus present in the lymph node biopsies from all of these HIV-infected patients, and in vitro studies demonstrated that exposure of monocytic cells carrying latent HIV to HHV-6A resulted in massive upregulation of HIV replication from latency. Thus, active HHV-6 infections appear relatively early in the course of HIV disease, and in vitro studies suggest that the A variant of HHV-6 is capable of breaking HIV latency, with the potential for helping to catalyze the progression of HIV infection to AIDS.
引用
收藏
页码:370 / 378
页数:9
相关论文
共 43 条
[21]   HUMAN HERPESVIRUS-6 INDUCES INTERLEUKIN-1-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA, BUT NOT INTERLEUKIN-6, IN PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURES [J].
FLAMAND, L ;
GOSSELIN, J ;
DADDARIO, M ;
HISCOTT, J ;
ABLASHI, DV ;
GALLO, RC ;
MENEZES, J .
JOURNAL OF VIROLOGY, 1991, 65 (09) :5105-5110
[22]  
FOLKS TM, 1988, J IMMUNOL, V140, P1117
[23]  
GALLO RC, 1988, J ACQ IMMUN DEF SYND, V1, P521
[24]   CHRONIC BONE-MARROW SUPPRESSION IN IMMUNOCOMPETENT ADULT BY HUMAN HERPESVIRUS-6 [J].
GOMPELS, UA ;
LUXTON, J ;
KNOX, KK ;
CARRIGAN, DR .
LANCET, 1994, 343 (8899) :735-736
[25]   RAPID TURNOVER OF PLASMA VIRIONS AND CD4 LYMPHOCYTES IN HIV-1 INFECTION [J].
HO, DD ;
NEUMANN, AU ;
PERELSON, AS ;
CHEN, W ;
LEONARD, JM ;
MARKOWITZ, M .
NATURE, 1995, 373 (6510) :123-126
[26]   HUMAN HERPESVIRUS 6 INHIBITS THE PROLIFERATIVE RESPONSES OF HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
HORVAT, RT ;
PARMELY, MJ ;
CHANDRAN, B .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (06) :1274-1280
[27]   PROGRESSIVE IMMUNODEFICIENCY AND FATAL PNEUMONITIS ASSOCIATED WITH HUMAN HERPESVIRUS-6 INFECTION IN AN INFANT [J].
KNOX, KK ;
PIETRYGA, D ;
HARRINGTON, DJ ;
FRANCIOSI, R ;
CARRIGAN, DR .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) :406-413
[28]   DISSEMINATED ACTIVE HHV-6 INFECTIONS IN PATIENTS WITH AIDS [J].
KNOX, KK ;
CARRIGAN, DR .
LANCET, 1994, 343 (8897) :577-578
[29]   INVITRO SUPPRESSION OF BONE-MARROW PROGENITOR-CELL DIFFERENTIATION BY HUMAN HERPESVIRUS-6 INFECTION [J].
KNOX, KK ;
CARRIGAN, DR .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (05) :925-929
[30]   INFECTION OF NATURAL-KILLER-CELLS BY HUMAN HERPESVIRUS-6 [J].
LUSSO, P ;
MALNATI, MS ;
GARZINODEMO, A ;
CROWLEY, RW ;
LONG, EO ;
GALLO, RC .
NATURE, 1993, 362 (6419) :458-462